Parker Waichman LLP Headlines by Topic
Drug Coated Stents
Medtronic Shares Fall on Questions About Stent
Oct 17, 2008
| Parker Waichman LLP
We have been writing about a number of findings related to stents that were revealed at the Transcatheter Cardiovascular Therapeutics meeting that...
Senators Probe Industry Ties to Medical Device Conference Organizers
Oct 17, 2008
| Parker Waichman LLP
Two lawmakers have written to the organizers of the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C. about the...
Surgery Deemed More Effective Than Boston Scientifics’ Taxus Stent
Sep 2, 2008
| Parker Waichman LLP
Doctors are now reporting that Boston Scientific Corporation’s Taxus stent did not fare as well as bypass surgery in improving medical outcomes...
Heart Stents No Better than Drugs in the Long Run
Aug 14, 2008
| Parker Waichman LLP
An international team of researchers just reported in the New England Journal of Medicine that while using drugs alone may take longer than...
Boston Scientific Stent Study Questioned by Wall Street Journal
Aug 14, 2008
| Parker Waichman LLP
The Wall Street Journal is reporting that a study used by Boston Scientific in its quest to garner U.S. approval for its Taxus Liberte stent used a...
Use of Coated Stents on the Rise, But How Safe Are They?
Jul 16, 2008
| Parker Waichman LLP
Experts disagree on whether stent science is moving too fast and doctors are concerned that blood clots can form at the site of drug-coated stents...
Cypher Stent Ad Criticized
May 15, 2008
| Parker Waichman LLP
A 60-second television ad for the Cypher drug coated stent—made by the Cordis subsidiary of Johnson & Johnson—is under fire. It...
Drug Coated Stent Debate Yet to be Resolved
May 12, 2008
| Parker Waichman LLP
Experts continue to disagree on the usefulness and safety of drug coated stents. Stents are an important element in heart-disease...
Why the Rush to Approve Drug Coated Stents?
Apr 25, 2008
| Parker Waichman LLP
The new Xience heart stent out-performed the more popular Taxus heart stent in a one-year trial; however, experts disagree on whether stent science...
FDA Releases Drug Coated Stent Guidelines
Mar 27, 2008
| Parker Waichman LLP
Drug coated stents should be subject to more stringent clinical trials before approval, and makers of such devices should conduct long-term follow-up...
